WuXi PharmaTech (Cayman), Inc. (ADR) (NYSE:WX)

CAPS Rating: 4 out of 5

China-based pharmaceutical and biotechnology R&D outsourcing company which provides a integrated portfolio of laboratory and manufacturing services in the drug discovery and development process to pharmaceutical and biotechnology companies.


Player Avatar tskephart (89.33) Submitted: 11/26/2008 12:30:32 PM : Outperform Start Price: $5.97 WX Score: +350.51

Pharmaceutical R&D is a very expensive part of the pharmaceutical market. I feel their will be a paradigm shift on how global pharmaceutical companies approach research, one of the results will be more outsourcing and collaborations.. WuXi is positioned well to take advantage of this shift.

Member Avatar timothy55 (< 20) Submitted: 2/11/2012 7:40:59 PM
Recs: 0

I am surprised this stock is not trading 20-30% higher!

Featured Broker Partners